Neqstent receives
CE Mark approval:

 

Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Assisted Flow Diverter, Designed to Treat Intracranial Aneurysms

Contour 021 receives CE Mark approval: 

Cerus Endovascular Receives CE Mark Approval for its 

Contour 021 device

2nd Cerus Webinar - 
May 21st 18:00h CET 

"Complex Treatment of Wide Necked Bifurcation Aneurysms" 

What's new at Cerus Endo?

Exhibition Schedule 2020

We'll be at key European congresses throughout 2020, to connect with existing partners and meeting new ones.

Cerus-handshake-icon.png
Opportunities 

We are always keen to hear from new talent, about partnerships or distribution enquiries.

Investors

Learn more about Cerus and the experience, knowledge and backgrounds of our Board of Directors.

Sign up for regular updates

Keep up to date on all Cerus Endovascular news by signing up to our newsletter.

Cerus Endovascular is an ISO 13485:2016 certified company. © 2019 Cerus Endovascular Inc. All rights reserved.

Cerus Endovascular Inc. 47757 Fremont Boulevard, Fremont, CA 94538 USA

APM007-01.O  11th of May  2020

Tel: +1 (510) 651 4000